Skip to main content

Stereotactic Ablative Radiotherapy (SABR) as a New Precision Treatment Option in Kidney Cancer

Project Member(s): De Abreu Lourenco, R.

Funding or Partner Organisation: Cancer Australia (Priority-driven Collaborative Cancer Research Scheme)
Cancer Australia (Priority-driven Collaborative Cancer Research Scheme)

Start year: 2018

FOR Codes: Health Economics, Health Policy Economic Outcomes, Health economics , Evaluation of health and support services not elsewhere classified, Health policy evaluation